Researchers have uncovered insights into the role of the gut microbiome in INDY-related longevity in Drosophila, revealing that the INDY gene, a plasma membrane citrate transporter, plays a pivotal role in promoting metabolic homeostasis and extending lifespan. By investigating the gut microbiome’s contribution to longevity, the study highlights how Indy reduction not only enhances lifespan but also preserves intestinal barrier integrity and stem cell homeostasis in the fly midgut.

The findings indicate that Indy heterozygote flies exhibit significantly lower bacterial loads and increased microbial diversity during aging compared to control flies. Notably, while the microbiome is not essential for the lifespan extension associated with Indy down-regulation, its removal appears to amplify the longevity effects of Indy reduction. This suggests a complex interaction between the microbiome and Indy that warrants further exploration. The study also links Indy down-regulation to decreased expression of JAK/STAT signaling ligands (Upd3 and Upd2) in the midgut of young flies, which likely contributes to the preservation of intestinal stem cell homeostasis.

The implications of these findings are substantial for the field of longevity research. They suggest that targeting the JAK/STAT signaling pathway and understanding the microbiome’s role in metabolic processes could open new avenues for therapeutic development aimed at promoting healthspan. As researchers delve deeper into the intricate relationships between gut microbes and genetic factors influencing longevity, this study underscores the potential for microbiome modulation as a strategy for enhancing lifespan and mitigating age-related pathologies.

Source: fightaging.org